default author photo

Cecil Czerkinsky

Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology

Valbonne

France

SCHOLARLY PAPERS

2

DOWNLOADS

642

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

Number of pages: 27 Posted: 22 Jul 2021
Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Université Côte d'Azur - Clinical Research Unit Côte d’Azur, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Department of Immunology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, University Côte d’Azur, CNRS - Laboratory of Molecular Physio Medicine, University Côte d’Azur, CNRS - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Nice University Hospital - Laboratory of Clinical and Experimental Pathology, Nice University Hospital - Department of Immunology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Laboratory of Clinical and Experimental Pathology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Nice University Hospital - Department of Immunology, University Côte d’Azur, CNRS - Institute of Molecular and Cellular Pharmacology and Nice University Hospital - Department of Nephrology, Dialysis and Transplantation
Downloads 592 (113,998)
Citation 2

Abstract:

Loading...

2.

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients

Number of pages: 21 Posted: 13 Dec 2021
Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur - Autonomy Aging Rehabilitation Department, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur - Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur - Autonomy Aging Rehabilitation Department, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN) and Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology
Downloads 50 (1,063,489)

Abstract:

Loading...

mucosal immunity, secretory antibodies, SARS-CoV-2, COVID-19 mRNA vaccine